The questions hospitals ask us most — answered plainly.
No. PHI stays inside your hospital network. The Clinical Trust Layer detects and masks identifiers before any AI processing, connections to models are governed, authenticated, and encrypted, and you can deploy fully on-premises or in your private cloud. The hospital retains complete ownership and control of its clinical data — always.
Never. The MI prepares and proposes; the board decides — always. There is no autonomous diagnosis: every suggestion is accepted, adjusted, or dismissed by clinicians, and the final decision is recorded as a human decision with its rationale and supporting evidence.
Treatment options are aligned to leading guideline frameworks such as NCCN, ESMO, and ICMR, retrieved through RAG so every recommendation is grounded in a real guideline paragraph — cited and linked. Guideline content is cached in-network, so nothing phones home.
Yes. HEALiX is model-agnostic by design: each discipline agent can run on the best model for its task — a genomics-tuned model for variant interpretation, an imaging-appropriate model for radiology — or on your own self-hosted LLM. Model abstraction means you can swap models freely as the field evolves, with no vendor lock-in.
Structurally. Every statement must link to its exact source — a pathology-report line, a guideline paragraph, a trial record. Citation enforcement happens in code: an unsourced statement is suppressed, never rendered. A critic agent cross-examines every claim, and if a source returns nothing, HEALiX says so rather than invent.
Everything a tumor board actually receives: DICOM imaging, scanned PDF pathology reports, NGS genomics panels, free-text clinical notes, patient history, labs, and prior treatment records. It connects to your existing EMR, HIS, LIS, and PACS through standards like FHIR, HL7, and DICOM.
The MI assembles each case from its files, builds the disease timeline, and flags gaps — a missing MSI/MMR result, a pending IHC — days before the meeting instead of during it. A close-gate ensures a meeting can’t end until every case has a recorded outcome.
Minutes and action points are drafted from the discussion itself and are editable before they become official. Decisions are documented with responsible clinicians and next actions, signed off by the chair, and tracked through to adherence and outcome — a complete audit trail.
Yes — by default. Complete tumor-board documentation, decision trails, and quality metrics are generated as a by-product of normal use, giving you traceable records that stand up to certification, quality-programme, and regulatory review.
HEALiX is clinical decision support designed with the clinician in command — it prepares and proposes, and licensed clinicians decide. It is designed in alignment with IMDRF SaMD guidance and applicable frameworks such as DPDP, HIPAA, GDPR, and ISO 27001; the applicable regulatory pathway depends on your region and deployment.
The platform is purpose-built for tumor boards first — that is where multidisciplinary complexity is highest. The same architecture of discipline agents, orchestration, and the Clinical Trust Layer is designed to extend to other multidisciplinary team settings over time.
Request a demo. We’ll walk your team through an illustrative case end to end, then scope a pilot around your hospital’s systems, governance requirements, and board volume.